Stock News

Capwealth Advisors Has Decreased Stake in Gilead Sciences (GILD) as Stock Price Declined; Microsoft (MSFT) Share Price Rose While Cue Financial Group Increased Holding by $552,097

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Cue Financial Group Inc increased its stake in Microsoft Corp (MSFT) by 25.62% based on its latest 2018Q1 regulatory filing with the SEC. Cue Financial Group Inc bought 6,067 shares as the company’s stock rose 3.08% while stock markets declined. The institutional investor held 29,750 shares of the prepackaged software company at the end of 2018Q1, valued at $2.72 million, up from 23,683 at the end of the previous reported quarter. Cue Financial Group Inc who had been investing in Microsoft Corp for a number of months, seems to be bullish on the $769.32 billion market cap company. The stock decreased 1.27% or $1.29 during the last trading session, reaching $100.13. About 37.25M shares traded or 26.19% up from the average. Microsoft Corporation (NASDAQ:MSFT) has risen 41.28% since June 17, 2017 and is uptrending. It has outperformed by 28.71% the S&P500. Some Historical MSFT News: 22/03/2018 – Allure Security to Exhibit at RSA Conference 2018; 16/05/2018 – Businesses still use email but are moving toward clients like Slack, Microsoft Teams and Google Hangouts; 26/03/2018 – Microsoft in the Trillion-Dollar Club? Cloud Will Get It There, Says Morgan Stanley — Barron’s Blog; 02/04/2018 – Symic Bio Announces 12-Month Results from the SHIELD Trial of SB-030 in Peripheral Vascular Disease; 26/03/2018 – Coutts banker quits after report of harassment complaints in 2015; 29/03/2018 – MICROSOFT – FORMATION OF TWO NEW ENGINEERING TEAMS; 07/05/2018 – MICROSOFT, AMAZON DEMO TOOK PLACE AT MICROSOFT CONFERENCE; 04/04/2018 – The Register: They forked this one up: Microsoft modifies open-source code, blows hole in Windows Defender; 12/04/2018 – Astreya Names Jay Preston SVP Global Service Delivery; 30/05/2018 – Microsoft hosts ribbon-cutting ceremony for Microsoft Software & Systems Academy servicing the Jacksonville military community

Capwealth Advisors Llc decreased its stake in Gilead Sciences Inc (GILD) by 3.14% based on its latest 2018Q1 regulatory filing with the SEC. Capwealth Advisors Llc sold 4,746 shares as the company’s stock declined 17.62% with the market. The institutional investor held 146,466 shares of the health care company at the end of 2018Q1, valued at $11.04 million, down from 151,212 at the end of the previous reported quarter. Capwealth Advisors Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $91.32 billion market cap company. The stock decreased 1.29% or $0.92 during the last trading session, reaching $70.23. About 7.67M shares traded or 5.28% up from the average. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 4.37% since June 17, 2017 and is uptrending. It has underperformed by 8.20% the S&P500. Some Historical GILD News: 20/04/2018 – STAT Plus: NIH is sued for plans to award exclusive license for CAR-T therapy to Gilead; 23/04/2018 – Gilead’s Descovy Falls After 2-Wk Rise, Triumeq Declines: HIV; 28/03/2018 – Rob Portman: Portman Tours Mt. Gilead Maryhaven Center and Hosts Opioid Roundtable Discussion with the Morrow County Opiate; 30/04/2018 – GILEAD & VERILY REPORT SCIENTIFIC PACT TO IDENTIFY & UNDERSTAND; 25/04/2018 – MERCK LOSES BID TO REVIVE $200 MILLION VERDICT AGAINST GILEAD; 05/03/2018 – GlaxoSmithKline: ViiV Healthcare Announces Positive New Dolutegravir Data; 21/05/2018 – Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1; 18/05/2018 – FDA- PRELIM RESULTS FROM ONGOING STUDY FOUND WOMEN GETTING DOLUTEGRAVIR AT TIME OF BECOMING PREGNANT/EARLY IN FIRST TRIMESTER APPEAR AT HIGHER RISK FOR DEFECTS; 15/03/2018 – STAT Plus: HHS is urged to investigate a Gilead hepatitis C patent for failing to disclose federal funding; 30/04/2018 – AbbVie’s Mavyret Rises After 1-Wk Fall, Epclusa Advances: Hep-C

Capwealth Advisors Llc, which manages about $719.93M and $517.14M US Long portfolio, upped its stake in Carnival Corp Paired Ctf1 Com (NYSE:CCL) by 7,833 shares to 191,055 shares, valued at $12.53 million in 2018Q1, according to the filing. It also increased its holding in Fedl Natl Mtg Assn Non Cu (FNMAT) by 242,685 shares in the quarter, for a total of 1.12 million shares, and has risen its stake in Citigroup Inc New (NYSE:C).

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on July, 25. They expect $1.42 EPS, down 43.43% or $1.09 from last year’s $2.51 per share. GILD’s profit will be $1.85 billion for 12.36 P/E if the $1.42 EPS becomes a reality. After $1.37 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts 3.65% EPS growth.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Nasdaq.com which released: “Biotech ETFs Are the Best Way to Play the Recovering Sector” on May 30, 2018, also Seekingalpha.com with their article: “Gilead: Novartis’s Kymriah Is Coming To America” published on May 24, 2018, Seekingalpha.com published: “The Kite Killer – TapImmune And Marker Merger Challenges Gilead” on May 30, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Nasdaq.com and their article: “5 Top Stocks to Buy in June” published on June 01, 2018 as well as Fool.com‘s news article titled: “1 Under-the-Radar Dividend Growth Stock to Buy Right Now” with publication date: June 17, 2018.

Since January 2, 2018, it had 0 buys, and 23 sales for $48.21 million activity. $8.02M worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Meyers James R on Tuesday, January 16. MARTIN JOHN C sold $3.41 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, June 1. Alton Gregg H also sold $1.18M worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, February 20. Washington Robin L also sold $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares. $4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by WILSON GAYLE E on Friday, February 9.

Among 31 analysts covering Gilead Sciences (NASDAQ:GILD), 22 have Buy rating, 0 Sell and 9 Hold. Therefore 71% are positive. Gilead Sciences had 132 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Monday, June 12 by Jefferies. The rating was maintained by Credit Suisse with “Outperform” on Wednesday, September 14. The rating was maintained by Oppenheimer on Tuesday, October 20 with “Outperform”. BMO Capital Markets maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, January 2 with “Hold” rating. Cowen & Co maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, February 7 with “Buy” rating. On Wednesday, February 7 the stock rating was maintained by BMO Capital Markets with “Hold”. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, October 6. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, February 7 report. Wells Fargo maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Monday, January 29 with “Buy” rating. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Tuesday, October 25. Jefferies has “Buy” rating and $95 target.

Investors sentiment increased to 0.88 in 2018 Q1. Its up 0.08, from 0.8 in 2017Q4. It improved, as 71 investors sold GILD shares while 519 reduced holdings. 114 funds opened positions while 404 raised stakes. 976.44 million shares or 0.39% more from 972.68 million shares in 2017Q4 were reported. Ibm Retirement Fund reported 30,833 shares stake. Stonebridge Capital Mngmt Inc holds 1.4% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 50,945 shares. The New York-based Rafferty Asset Management Limited Liability Com has invested 0.02% in Gilead Sciences, Inc. (NASDAQ:GILD). Employees Retirement Sys Of Texas invested in 0.45% or 436,900 shares. Cornerstone Cap Inc holds 0.8% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 64,516 shares. Moreover, Koshinski Asset Mngmt has 0.15% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Telemus Ltd Liability reported 0.06% in Gilead Sciences, Inc. (NASDAQ:GILD). Manufacturers Life Insurance Communication The invested in 5.06M shares or 0.42% of the stock. Prentiss Smith & Company Inc has invested 0.26% in Gilead Sciences, Inc. (NASDAQ:GILD). Federated Investors Pa stated it has 0.01% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Oak Associates Limited Oh has invested 1.05% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Virginia Retirement Et Al reported 0.08% in Gilead Sciences, Inc. (NASDAQ:GILD). Moreover, Atlantic Tru Group Incorporated Limited Liability has 0.06% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 185,521 shares. Nexus Inv Management reported 259,341 shares. Windward Capital Mngmt Com Ca accumulated 40,503 shares or 0.44% of the stock.

Cue Financial Group Inc, which manages about $333.03 million and $151.47M US Long portfolio, decreased its stake in Berkshire Hathaway Inc Del (BRKB) by 1,772 shares to 4,772 shares, valued at $952,000 in 2018Q1, according to the filing. It also reduced its holding in Ishares Tr (PFF) by 26,920 shares in the quarter, leaving it with 21,186 shares, and cut its stake in Medley Cap Corp (NYSE:MCC).

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Finance.Yahoo.com which released: “Microsoft Corporation (NASDAQ:MSFT) Strikes Deal To Acquire Github” on June 04, 2018, also Seekingalpha.com with their article: “Microsoft: How The Acquisition Of GitHub Reflects Where The Modern Corporation Is Going” published on June 06, 2018, Seekingalpha.com published: “Can Cloud-Based Growth Sustain Microsoft Going Forward?” on June 04, 2018. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Seekingalpha.com and their article: “Microsoft takes aim at Amazon Go” published on June 14, 2018 as well as Thestreet.com‘s news article titled: “Why Microsoft Is Ratcheting Up Its Hardware and Chip Ambitions” with publication date: June 14, 2018.

Among 37 analysts covering Microsoft Corporation (NASDAQ:MSFT), 31 have Buy rating, 1 Sell and 5 Hold. Therefore 84% are positive. Microsoft Corporation had 196 analyst reports since July 22, 2015 according to SRatingsIntel. Canaccord Genuity maintained Microsoft Corporation (NASDAQ:MSFT) on Thursday, January 25 with “Buy” rating. FBN Securities maintained it with “Outperform” rating and $65 target in Wednesday, July 20 report. Bernstein maintained Microsoft Corporation (NASDAQ:MSFT) on Wednesday, November 15 with “Buy” rating. Tigress Financial maintained the stock with “Buy” rating in Tuesday, November 7 report. Goldman Sachs maintained the stock with “Buy” rating in Tuesday, July 18 report. Wunderlich maintained Microsoft Corporation (NASDAQ:MSFT) on Wednesday, July 20 with “Hold” rating. As per Monday, March 26, the company rating was maintained by Morgan Stanley. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Sell” rating given on Thursday, October 26 by Jefferies. UBS maintained Microsoft Corporation (NASDAQ:MSFT) rating on Monday, November 23. UBS has “Buy” rating and $60.0 target. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Buy” rating given on Friday, January 12 by Barclays Capital.

Since February 16, 2018, it had 1 buy, and 4 selling transactions for $1.39 million activity. $325,500 worth of Microsoft Corporation (NASDAQ:MSFT) was sold by Capossela Christopher C on Friday, February 23.

Investors sentiment decreased to 0.74 in Q1 2018. Its down 0.03, from 0.77 in 2017Q4. It turned negative, as 49 investors sold MSFT shares while 1035 reduced holdings. 142 funds opened positions while 665 raised stakes. 5.38 billion shares or 1.45% less from 5.46 billion shares in 2017Q4 were reported. Commonwealth Of Pennsylvania Pub School Empls Retrmt Systems invested 0.87% in Microsoft Corporation (NASDAQ:MSFT). Vestor Cap Ltd Liability Company accumulated 182,116 shares. Pring Turner Capital Grp holds 1.84% in Microsoft Corporation (NASDAQ:MSFT) or 19,405 shares. Vnbtrust National Association reported 13,367 shares stake. 377,752 are held by Gam Holdg Ag. Jolley Asset Mgmt Ltd has invested 0.23% in Microsoft Corporation (NASDAQ:MSFT). 284 were reported by Sageworth Tru. Impala Asset Mgmt Lc owns 49,236 shares. Van Hulzen Asset Mngmt Ltd Liability Company stated it has 12,860 shares or 0.36% of all its holdings. Logan Capital Management Inc invested 1.26% in Microsoft Corporation (NASDAQ:MSFT). Smith Asset Management Grp Limited Partnership holds 1.31 million shares or 3.94% of its portfolio. Bellecapital Limited has 7,983 shares. Shell Asset Management invested 2.3% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Gateway Invest Advisers has invested 3.19% in Microsoft Corporation (NASDAQ:MSFT). Clean Yield Gru holds 1.34% or 34,681 shares.

Microsoft Corporation (NASDAQ:MSFT) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *